Throcare Technologies Ltd Share Price & Stock Analysis

Throcare Technologies Ltd (BSE: 539871) is a Navi Mumbai, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹7,764 Cr, it ranks #671 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 18 in Medical Diagnostic Centres. At ₹497.95 (as of 16 Nov 2026), the share price is 24.8% below its 52-week high of ₹662.00 and 45.4% above its 52-week low of ₹342.55. The share price is up 7.5% over one year and down 17.8% over three months.

Key Metrics

Current Price₹497.95
Market Cap₹7,764 Cr
BSE Code539871
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio47.6
Return on Equity28.74%
Return on Assets17.69%
52-Week Range₹342.55 – ₹662.00
1-Year Price Change+7.5%
3-Month Price Change-17.8%
Beta (1Y)0.84
Dividend Yield2.88%
HeadquartersNavi Mumbai, Maharashtra
Websitewww.thyrocare.com

Latest Quarterly Results — Q2 FY27

Revenue₹271 Cr
Net Profit₹15 Cr
Net Margin5.6%
EPS (Basic)₹0.96
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Throcare Technologies Ltd Quarterly Revenue and Profit Trend

Throcare Technologies Ltd reported revenue of ₹271 Cr in Q2 FY27, up 25.1% from ₹217 Cr in Q2 FY26 and up 12.8% from ₹240 Cr in Q1 FY27. It posted a net profit of ₹15 Cr for the quarter, against a net profit of ₹48 Cr in Q2 FY26 (down 68.2%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹187 Cr (Q4 FY25) to ₹271 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹271 Cr₹15 Cr5.6%
Q1 FY27₹240 Cr₹51 Cr21.4%
Q4 FY26₹224 Cr₹49 Cr21.7%
Q3 FY26₹196 Cr₹28 Cr14.3%
Q2 FY26₹217 Cr₹48 Cr22.1%
Q1 FY26₹193 Cr₹38 Cr19.8%
Q4 FY25₹187 Cr₹22 Cr11.5%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 51.02% of Throcare Technologies Ltd's shares as of Sept 2026, against 71.06% in Sept 2025 (−20.04 percentage points). Delivery averaged 49.3% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Throcare Technologies Ltd

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Products and Services

1. Diagnostic Testing Services-This segment provides laboratory testing services. 2. Imaging Services-This segment provides PET-CT scanning services; and sells radio pharmaceuticals used in imaging services. 3. Others-This segment engages in trading and other related business activities. 4. Unallocable Assets-0

Business Segments

1. Diagnostic Testing Services-93.2% 2. Imaging Services-6.4% 3. Others-0.4%

Throcare Technologies Ltd vs Peers — Medical Diagnostic Centres

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Dr. Lal Pathlabs Ltd₹33,934 Cr66.421.48%₹874 Cr+28.7%
Vijaya Diagnostic Centre Limited₹14,665 Cr84.319.70%₹255 Cr+38.5%
Metropolis Healthcare Limited₹11,952 Cr61.513.37%₹497 Cr+14.9%
Throcare Technologies Ltd₹7,764 Cr47.628.74%₹271 Cr+7.5%
SURAKSHA DIAGNOSTIC LIMITED₹1,856 Cr55.413.84%₹99 Cr+6.9%
Krsnaa Diagnostics Ltd₹1,625 Cr16.810.89%₹271 Cr-27.0%
Gaudium IVF and Women Health Limited₹803 Cr27.416.08%₹37 Cr—
Chandan Healthcare Limited₹582 Cr21.918.43%₹81 Cr—
Aspira Pathlab & Diagnostics Ltd₹127 Cr2,360——+115.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Throcare Technologies Ltd?

Throcare Technologies Ltd is trading at ₹497.95, with a market capitalisation of ₹7,764 Cr.

Which sector does Throcare Technologies Ltd belong to?

Throcare Technologies Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Throcare Technologies Ltd?

Throcare Technologies Ltd has a P/E of 47.6 and a return on equity of 28.74%.

What is the stock symbol of Throcare Technologies Ltd?

Throcare Technologies Ltd is listed on the BSE under the scrip code 539871.

How has Throcare Technologies Ltd's share price moved over the past year?

Throcare Technologies Ltd's share price is up 7.5% over one year and down 17.8% over three months. Its 52-week range is ₹342.55 to ₹662.00.

What were Throcare Technologies Ltd's latest quarterly results?

In Q2 FY27, Throcare Technologies Ltd reported revenue of ₹271 Cr and net profit of ₹15 Cr, with basic EPS of ₹0.96 (consolidated, parsed from the company's exchange filing).

How have Throcare Technologies Ltd's revenue and profit changed over the past year?

Throcare Technologies Ltd reported revenue of ₹271 Cr in Q2 FY27, up 25.1% from ₹217 Cr in Q2 FY26 and up 12.8% from ₹240 Cr in Q1 FY27.

What is the promoter holding in Throcare Technologies Ltd?

Promoters held 51.02% of Throcare Technologies Ltd's shares as of Sept 2026, against 71.06% in Sept 2025 (−20.04 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.